The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Salgia, Ravi
One or more keywords matched the following items that are connected to Salgia, Ravi
Item TypeName
Concept Adjuvants, Immunologic
Concept Growth Inhibitors
Concept Enzyme Inhibitors
Concept Immunologic Surveillance
Concept Dose-Response Relationship, Drug
Concept Immune Tolerance
Concept Immunologic Capping
Concept Immune System Diseases
Concept Immunotherapy
Concept Enzyme-Linked Immunosorbent Assay
Concept Immunohistochemistry
Concept Protease Inhibitors
Concept Immunoenzyme Techniques
Concept Receptors, Immunologic
Concept Angiogenesis Inhibitors
Concept Immunoconjugates
Concept Topoisomerase I Inhibitors
Concept Chromatin Immunoprecipitation
Concept Cyclin-Dependent Kinase Inhibitor p21
Concept Structure-Activity Relationship
Concept Immunoprecipitation
Concept Immunoblotting
Concept Topoisomerase Inhibitors
Concept Inhibitory Concentration 50
Concept Cell Cycle Checkpoints
Concept G1 Phase Cell Cycle Checkpoints
Concept Immune Evasion
Concept Cyclin-Dependent Kinase Inhibitor p27
Concept Immunity
Concept Protein Kinase Inhibitors
Academic Article The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells.
Academic Article Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Academic Article Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Academic Article Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Academic Article A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.
Academic Article ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
Academic Article BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.
Academic Article Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Academic Article CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.
Academic Article Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.
Academic Article Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Academic Article Role of receptor tyrosine kinases in lung cancer.
Academic Article Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
Academic Article Flow cytometric determination of lipid peroxidation using fluoresceinated phosphoethanolamine.
Academic Article Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
Academic Article Targeted molecules in small cell lung cancer.
Academic Article Small-cell cancers, and an unusual reaction to chemotherapy. Case 1. Extrapulmonary small-cell carcinoma arising in the prostate.
Academic Article Targeting c-Kit mutations: basic science to novel therapies.
Academic Article Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system.
Academic Article Phase II study of imatinib in patients with small cell lung cancer.
Academic Article Therapeutic targeting of the receptor tyrosine kinase Met.
Academic Article A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Academic Article Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.
Academic Article c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Academic Article Novel therapies in lung cancer.
Academic Article Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Academic Article A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Academic Article Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
Academic Article c-Met inhibition.
Academic Article A review of topoisomerase inhibition in lung cancer.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.
Academic Article PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Academic Article Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Academic Article Protein kinase C beta in malignant pleural mesothelioma.
Academic Article EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article Receptor tyrosine kinases and inhibitors in lung cancer.
Academic Article Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
Academic Article Role of c-Met in cancer: emphasis on lung cancer.
Academic Article EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
Academic Article Ethnic differences and functional analysis of MET mutations in lung cancer.
Academic Article Fyn: a novel molecular target in cancer.
Academic Article Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors.
Academic Article CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
Academic Article Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Academic Article Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Academic Article Non-receptor tyrosine kinase inhibitors in lung cancer.
Academic Article FYN is overexpressed in human prostate cancer.
Academic Article Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion.
Academic Article Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
Academic Article Differential expression of RON in small and non-small cell lung cancers.
Academic Article Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Academic Article Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Academic Article CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.
Academic Article Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid.
Academic Article MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
Academic Article Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation.
Academic Article c-Met is a potentially new therapeutic target for treatment of human melanoma.
Academic Article Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL.
Academic Article The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Academic Article Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
Academic Article Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Academic Article Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Academic Article Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
Academic Article Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Academic Article A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
Academic Article Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.
Academic Article Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
Academic Article A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Academic Article Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Academic Article Novel targets for therapeutic agents in small cell lung cancer.
Academic Article The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Academic Article Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
Academic Article RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Academic Article Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Academic Article Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible.
Academic Article Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.
Academic Article The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article EphB4 as a therapeutic target in mesothelioma.
Academic Article TLR3 agonists and proinflammatory antitumor activities.
Academic Article MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Academic Article Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.
Academic Article Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.
Academic Article Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Academic Article Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.
Academic Article Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
Academic Article A new hope for precision medicine.
Academic Article A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
Academic Article A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors.
Academic Article Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Academic Article A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Academic Article Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin.
Academic Article Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Academic Article Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Academic Article Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
Academic Article Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Academic Article Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Academic Article Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Academic Article FAK and paxillin, two potential targets in pancreatic cancer.
Academic Article Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Academic Article Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.
Academic Article Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Academic Article RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Academic Article TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Academic Article Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
Academic Article A phase I study of XL184, a RET, VEGFR2, and MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC).
Academic Article Refining epidermal growth factor receptor (EGFR) -inhibition-related rash (EIRR) phenotypes with a cetuximab (C) monotherapy stage of a phase II trial for non-small cell lung cancer (NSCLC).
Academic Article MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
Academic Article Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Academic Article Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
Academic Article Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
Academic Article Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
Academic Article Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
Academic Article A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
Academic Article Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.
Academic Article The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.
Academic Article Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer.
Academic Article Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.
Academic Article Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
Academic Article Presence and structure-activity relationship of intrinsically disordered regions across mucins.
Academic Article Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines.
Academic Article The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Academic Article Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
Academic Article Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors.
Academic Article MET receptor in oncology: From biomarker to therapeutic target.
Academic Article Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer.
Academic Article Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
Academic Article Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report.
Academic Article Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.
Academic Article Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence.
Academic Article Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.
Academic Article Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.
Academic Article Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM).
Academic Article Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations.
Academic Article Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors.
Academic Article Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors.
Academic Article Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions.
Academic Article Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
Academic Article JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.
Academic Article Infectious complications of immune checkpoint inhibitors in solid organ malignancies.
Academic Article Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC).
Academic Article Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.
Academic Article Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor.
Academic Article Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Academic Article Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
Academic Article Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy.
Academic Article Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Academic Article A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.
Concept Antineoplastic Agents, Immunological
Concept Inhibitor of Growth Protein 1
Concept Proteasome Inhibitors
Concept Drug-Related Side Effects and Adverse Reactions
Grant Role of Paxillin in Lung Cancer
Grant MINIMAL RESIDUAL TUMOR IN SMALL CELL LUNG CANCER
Grant Role of c-Met in SCLC and Potential for Novel Therapy
Grant Novel Targeted Therapy in Pancreatic Cancer
Grant Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Grant PAXILLIN--AN ONCOGENE ACTIVATED PROTEIN
Academic Article Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
Academic Article Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma.
Academic Article Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer.
Academic Article LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer.
Academic Article Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.
Academic Article Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors.
Academic Article Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.
Academic Article A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
Academic Article Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Search Criteria
  • immune
  • related
  • Adverse
  • Events
  • checkpoint
  • inhibitor
  • immunotherapy